CD49b, a major marker of regulatory T-cells type 1, predicts the response to antiviral therapy of recurrent hepatitis C after liver transplantation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Fabien, Stenard ^a,b   Olivier, Morales ^c   Khaldoun, Ghazal ^b   Vivian, Viallon ^d   Lynda, Aoudjehane ^b   Laurissa, Ouaguia ^c   Gautier, Goormachtigh ^c   Yvon, Calmus ^a,b   Nadira, Delhem ^c   Filomena, Conti ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT DE BIOLOGIE DE LILLE   (France)

^d Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTEGRIN; ANTIVIRUS AGENT; BIOLOGICAL MARKER; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN;

ADULT; AGED; BIOPSY; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C; HUMAN; IMMUNOLOGY; LIVER; LIVER TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HUMANS; INTEGRIN ALPHA2; INTERFERON-ALPHA; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

EID: 84893777129     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/290878     Document Type: Article

References (43)

1. Negro F., Hadengue A., Therapy of chronic hepatitis B. Revue Medicale Suisse 2006 2 77 1981 1985 2-s2.0-33748950629 (Pubitemid 44432599)
2. + T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. Journal of Infectious Diseases 2004 189 7 1140 1150 2-s2.0-1842555459 10.1086/382278 (Pubitemid 38457236)
3. Curry M. P., Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004 78 7 955 963 2-s2.0-6344263380 10.1097/01.TP.0000140927.63952.58 (Pubitemid 39391854)
4. - recipients. Transplantation 2004 77 12 1834 1842 2-s2.0-3042657300 10.1097/01.TP.0000130468. 36131.0D (Pubitemid 38822205)
5. Berenguer M., Prieto M., San Juan F., Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36, article 202
6. Thimme R., Oldach D., Chang K., Steiger C., Ray S. C., Chisari F. V., Determinants of viral clearance and persistence during acute hepatitis C virus infection. Journal of Experimental Medicine 2001 194 10 1395 1406 2-s2.0-0035914925 10.1084/jem.194.10.1395 (Pubitemid 33081515)
7. + T-cell response in acute hepatitis C. Gastroenterology 1999 117 4 933 941 2-s2.0-0032832514 10.1016/S0016-5085(99)70353-7 (Pubitemid 29468237)
8. Tsai S., Liaw Y., Chen M., Huang C., Kuo G. C., Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 2 449 458 2-s2.0-0031026553 (Pubitemid 27069071)
9. + T cells with memory-phenotype in patients with chronic hepatitis C. Journal of Medical Virology 2002 67 2 162 170 2-s2.0-0036252191 10.1002/jmv.2205 (Pubitemid 34493430)
10. O'Garra A., Vieira P., Regulatory T cells and mechanisms of immune system control. Nature Medicine 2004 10 8 801 805 2-s2.0-4043052238 10.1038/nm0804-801 (Pubitemid 39070850)
11. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunological Reviews 2001 182 18 32 2-s2.0-0035180065 10.1034/j.1600-065X. 2001.1820102.x (Pubitemid 33070205)
12. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α -chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 3 1151 1164 2-s2.0-0029150110
13. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology 2002 3 2 135 142 2-s2.0-0036170938 10.1038/ni759 (Pubitemid 34141443)
14. + regulatory T cells are dependent on CTLA-4 expression. European Journal of Immunology 2004 34 12 3485 3496 2-s2.0-10944233989 10.1002/eji.200324632 (Pubitemid 40012166)
15. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 5609 1057 1061 2-s2.0-0347785480 10.1126/science.1079490 (Pubitemid 36222930)
16. + T regulatory cells in humans. Human Immunology 2005 66 1 13 20 2-s2.0-19944369378 10.1016/j.humimm.2004.05. 016 (Pubitemid 40037706)
17. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 6652 737 742 2-s2.0-0030704726 10.1038/39614 (Pubitemid 27458961)
18. Rahmoun M., Foussat A., Groux H., Pène J., Yssel H., Chanez P., Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. International Archives of Allergy and Immunology 2006 140 2 139 149 2-s2.0-33646551167 10.1159/000092533 (Pubitemid 43725808)
19. Weiner H. L., Induction and mechanism of action of transforming growth factor- β -secreting Th3 regulatory cells. Immunological Reviews 2001 182 207 214 2-s2.0-0035186416 10.1034/j.1600-065X.2001.1820117.x (Pubitemid 33070220)
20. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004 40 5 1062 1071 2-s2.0-7044247947 10.1002/hep.20454 (Pubitemid 39425561)
21. Rushbrook S. M., Ward S. M., Unitt E., Vowler S. L., Lucas M., Klenerman P., Alexander G. J. M., Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. Journal of Virology 2005 79 12 7852 7859 2-s2.0-19944366276 10.1128/JVI.79.12. 7852-7859.2005 (Pubitemid 40756820)
22. + T cells during chronic hepatitis C virus infection. Journal of Virology 2005 79 12 7860 7867 2-s2.0-19944370822 10.1128/JVI.79.12.7860-7867.2005 (Pubitemid 40756821)
23. MacDonald A. J., Duffy M., Brady M. T., McKiernan S., Hall W., Hegarty J., Curry M., Mills K. H. G., CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. Journal of Infectious Diseases 2002 185 6 720 727 2-s2.0-0037086525 10.1086/339340 (Pubitemid 34226199)
24. + regulatory T cells. Transplant Immunology 2008 19 2 127 135 2-s2.0-43949086180 10.1016/j.trim.2008.02.003
25. + regulatory T lymphocytes. Nature Medicine 2008 14 1 88 92 2-s2.0-38049020656 10.1038/nm1688
26. + regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006 108 1 390 399 2-s2.0-33745633856 10.1182/blood-2006-01-0329 (Pubitemid 43990654)
27. Demirkiran A., Kok A., Kwekkeboom J., Kusters J. G., Metselaar H. J., Tilanus H. W., van der Laan L. J. W., Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transplantation 2006 12 2 277 284 2-s2.0-33244467229 10.1002/lt.20612 (Pubitemid 43273788)
28. + cells accompany allograft rejection in pediatric liver allograft recipients. Pediatric Transplantation 2009 13 1 70 80 2-s2.0-58149287911 10.1111/j.1399-3046.2008.00917.x
29. Carpentier A., Conti F., Stenard F., Aoudjehane L., Miroux C., Podevin P., Morales O., Chouzenoux S., Scatton O., Groux H., Auriault C., Calmus Y., Pancre V., Delhem N., Increased expression of regulatory tr1 cells in recurrent hepatitis C after liver transplantation. American Journal of Transplantation 2009 9 9 2102 2112 2-s2.0-69149083247 10.1111/j.1600-6143.2009.02743.x
30. Calmus Y., Duvoux C., Pageaux G., Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNalpha-2a plus ribavirin. Journal of Hepatology 2012 57 564
31. Carpentier A., Conti F., Carrière M., Aoudjehane L., Miroux C., Moralès O., Calmus Y., Groux H., Auriault C., Pancré V., Delhem N., Podevin P., Analysis of gene transcription in sera during chronic hepatitis C infection. Journal of Medical Virology 2009 81 3 473 480 2-s2.0-60049100950 10.1002/jmv.21398
32. + T cells. Current Opinion in Immunology 2009 21 3 281 285 2-s2.0-67049168780 10.1016/j.coi.2009.05.007
33. + regulatory T cells. Trends in Immunology 2006 27 12 541 544 2-s2.0-33751207432 10.1016/j.it.2006.10.002 (Pubitemid 44780852)
34. + regulatory T cells. Journal of Immunology 2006 177 6 3806 3813 2-s2.0-33748504567 (Pubitemid 44359914)
35. Firpi R. J., Abdelmalek M. F., Soldevila-Pico C., Cabrera R., Shuster J. J., Theriaque D., Reed A. I., Hemming A. W., Liu C., Crawford J. M., Nelson D. R., One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transplantation 2004 10 10 1240 1247 2-s2.0-6444236097 10.1002/lt.20238 (Pubitemid 39406077)
36. Akiyama M., Ichikawa T., Miyaaki H., Motoyoshi Y., Takeshita S., Ozawa E., Miuma S., Shibata H., Taura N., Nakao K., Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C. Intervirology 2010 53 3 154 160 2-s2.0-73649142104 10.1159/000274976
37. Feray C., Caccamo L., Alexander G. J. M., Ducot B., Gugenheim J., Casanovas T., Loinaz C., Gigou M., Burra P., Barkholt L., Esteban R., Bizollon T., Lerut J., Minello-Franza A., Bernard P.-H., Nachbaur K., Botta-Fridlund D., Bismuth H., Schalm S. W., Samuel D., European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999 117 3 619 625 2-s2.0-0032840172 10.1016/S0016-5085(99) 70454-3 (Pubitemid 29409247)
38. Forman L. M., Lewis J. D., Berlin J. A., Feldman H. I., Lucey M. R., The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002 122 4 889 896 2-s2.0-0036207348 (Pubitemid 34267271)
39. Dumortier J., Scoazec J., Chevallier P., Boillot O., Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. Journal of Hepatology 2004 40 4 669 674 2-s2.0-1642293907 10.1016/j.jhep.2003.12.015 (Pubitemid 38367790)
40. Rodriguez-Luna H., Khatib A., Sharma P., De Petris G., Williams J. W., Ortiz J., Hansen K., Mulligan D., Moss A., Douglas D. D., Balan V., Rakela J., Vargas H. E., Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α 2b and ribavirin: an open-label series. Transplantation 2004 77 2 190 194 2-s2.0-10744233319 10.1097/01.TP.0000100481.14514.BB (Pubitemid 38155744)
41. Manigold T., Racanelli V., T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. The Lancet Infectious Diseases 2007 7 12 804 813 2-s2.0-36348988986 10.1016/S1473-3099(07) 70289-X (Pubitemid 350152043)
42. +CD25 high regulatory T cells during acute hepatitis C virus infection. Journal of Infectious Diseases 2008 197 1 46 57 2-s2.0-39349117113 10.1086/523651 (Pubitemid 351263465)
43. + regulatory T cells suppresses ongoing arthritis. Journal of Autoimmunity 2009 34 4 390 399 2-s2.0-77952239724